ADIPOQ and breast cancer: Adiponectin inhibits leptin signaling by downregulating STAT3 activation, AKT phosphorylation, and WNT signaling by upregulating the suppressor of cytokine signaling 2, which inhibits BC cell proliferation and metastasis [45].